- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 271/06 - Esters of carbamic acids
Patent holdings for IPC class C07C 271/06
Total number of patents in this class: 51
10-year publication summary
|
2
|
1
|
3
|
3
|
1
|
4
|
5
|
1
|
3
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Soprema | 90 |
4 |
| Glioblastoma Foundation, Inc. | 7 |
3 |
| BASF SE | 21261 |
2 |
| Colgate-Palmolive Company | 5755 |
2 |
| FUJIFILM Corporation | 30424 |
2 |
| Asahi Kasei Chemicals Corporation | 564 |
2 |
| Relay Therapeutics, Inc. | 83 |
2 |
| Lantern Pharma Inc. | 91 |
2 |
| Inkbit, LLC | 76 |
2 |
| Chorda Pharma, Inc. | 8 |
2 |
| Boehringer Ingelheim International GmbH | 4495 |
1 |
| Bayer MaterialScience AG | 714 |
1 |
| Dow Global Technologies LLC | 10900 |
1 |
| The General Hospital Corporation | 4842 |
1 |
| Mitsui Chemicals, Inc. | 3242 |
1 |
| Axalta Coating Systems IP Co., LLC | 473 |
1 |
| Barclays Bank plc, AS Successor Agent | 120 |
1 |
| The Brigham and Women's Hospital, Inc. | 2279 |
1 |
| BYK-Chemie GmbH | 449 |
1 |
| Concert Pharmaceuticals, Inc. | 244 |
1 |
| Other owners | 18 |